The balance sheet restructuring is a positive for solvency but the underlying business is deteriorating sharply — revenue down 6.8%, adjusted EBITDA down 39%, and free cash flow turned negative. The large commercial payor loss is a structural headwind. Monitor the exchange offer participation rate and Q2 2026 results for stabilization. The stock may react positively to the debt deal in the near term but the fundamental trajectory remains bearish.
Price Chart
Executive Summary
Accendra Health reported Q1 2026 revenue of $627.8M (down 6.8% YoY from $673.9M) and a GAAP loss from continuing ops of -$0.08/share (vs -$0.05 a year ago), with adjusted EBITDA falling 39% to $58.4M. The company simultaneously announced a ~$1.5B balance sheet optimization transaction with existing creditors to extend maturities, reduce funded debt by up to ~$370M+, and lower leverage. The combination of deteriorating core operating results and a distressed recapitalization signals significant financial strain.
Key Financial Metrics
Key Facts
- Q1 2026 net revenue $627.8M, down 6.8% from $673.9M in Q1 2025
- GAAP loss from continuing ops -$0.08/share vs -$0.05/share YoY
- Adjusted EBITDA from continuing ops fell to $58.4M from $96.0M YoY (-39%)
- Free cash flow was -$2.0M vs +$35.6M in Q1 2025
- Announced ~$1.5B comprehensive balance sheet optimization with existing creditors
- Transaction includes refinancing 2027 Term Loan A, exchanging 2029/2030 notes, and extending RCF to 2030
- Discount capture reduces total debt by up to ~$115M assuming full participation
- Pro forma funded debt ~$1.75B vs $2.12B at 3/31/2026, weighted average life extended from ~2.7 to ~5.5 years
- Affirmed prior FY2026 guidance for net revenue and adjusted EBITDA
- Revenue decline driven by loss of a large commercial payor contract, partially offset by volume growth
Financial Impact
Revenue decline of $46.1M YoY (-6.8%), adjusted EBITDA decline of $37.6M (-39%), free cash flow swing of -$37.6M vs prior year. Balance sheet restructuring reduces funded debt by up to ~$370M+ and extends maturities by ~2.8 years.
Risk Factors
- Failed or partial consummation of the balance sheet optimization transaction
- Further revenue erosion from the terminated large commercial payor contract
- Inability to achieve cost reductions sufficient to offset revenue decline
- High interest expense on new 1L notes at 9.00% and 2L notes at 9.75%
- Shareholder dilution risk if equity is needed to complete the restructuring
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001104659-26-058226 |
| Document: ach-20260511x8k.htm | 0001104659-26-058226 |
| Document: ach-20260511xex99d2.htm | 0001104659-26-058226 |
| Document: 0001104659-26-058226-index-headers.html | 0001104659-26-058226 |
| Document: 0001104659-26-058226-index.html | 0001104659-26-058226 |
| Document: 0001104659-26-058226.txt | 0001104659-26-058226 |
| 8-K Data (Synthetic) | 0001104659-26-058226 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 9, 2026 18d ago | 8-K | $0.3905 $0.2202 | ▲ +43.61% | ▲ +42.12% | $0.2031 (+47.99%) |
Oct 7, 2026 20d ago | SC 13G | $0.4729 $0.3128 | ▼ −33.85% | ▼ −32.87% | $0.2031 (−57.05%) |
Sep 17, 2026 5w ago | 8-K | $1.03 $0.7332 | ▼ −28.82% | ▼ −29.42% | $0.2031 (−80.28%) |
Aug 17, 2026 10w ago | 8-K | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2031 (−81.02%) |
Aug 16, 2026 10w ago | Institutional Cluster | $1.07 $1.16 | ▲ +8.41% | ▲ +9.60% | $0.2031 (−81.02%) |
Aug 10, 2026 11w ago | 8-K | $1.26 $1.13 | ▼ −10.32% | ▼ −9.91% | $0.2031 (−83.88%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▲ +23.57% | ▲ +23.52% | $0.2031 (+85.49%) |
Aug 10, 2026 11w ago | 8-K | $1.40 $1.07 | ▼ −23.57% | ▼ −23.52% | $0.2031 (−85.49%) |
Jul 27, 2026 13w ago | EFFECT | $3.22 $3.41 | ▲ +5.90% | ▲ +3.39% | $0.2031 (−93.69%) |
Jun 25, 2026 17w ago | 8-K | $3.34 $3.59 | ▲ +7.49% | ▲ +5.32% | $0.2031 (−93.92%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers